These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 16784007

  • 1. Rhinitis medicamentosa.
    Ramey JT, Bailen E, Lockey RF.
    J Investig Allergol Clin Immunol; 2006; 16(3):148-55. PubMed ID: 16784007
    [Abstract] [Full Text] [Related]

  • 2. [Research progress on rhinitis medicamentosa].
    Wang YN, Luan ZL, Wang HT.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov 07; 52(11):872-875. PubMed ID: 29141305
    [Abstract] [Full Text] [Related]

  • 3. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G, de Gabory L, François M, Massé G, Bloch F, Brion N, Jankowski R, Serrano E.
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun 07; 130(3):137-44. PubMed ID: 23375990
    [Abstract] [Full Text] [Related]

  • 4. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B, Gotlib T, Samoliński B.
    Pol Merkur Lekarski; 2005 Sep 07; 19(111):288-90. PubMed ID: 16358845
    [Abstract] [Full Text] [Related]

  • 5. Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa.
    Akpinar ME, Yigit O, Akakin D, Sarioz O, Ozkan N, Yildiz SD, Azizli E, Sehirli US.
    Laryngoscope; 2012 Apr 07; 122(4):741-6. PubMed ID: 22374848
    [Abstract] [Full Text] [Related]

  • 6. Mucosal changes in rhinitis medicamentosa.
    Lin CY, Cheng PH, Fang SY.
    Ann Otol Rhinol Laryngol; 2004 Feb 07; 113(2):147-51. PubMed ID: 14994772
    [Abstract] [Full Text] [Related]

  • 7. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
    Graf P.
    Clin Ther; 1999 Oct 07; 21(10):1749-55. PubMed ID: 10566570
    [Abstract] [Full Text] [Related]

  • 8. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P.
    Rhinology; 1996 Mar 07; 34(1):9-13. PubMed ID: 8739860
    [Abstract] [Full Text] [Related]

  • 9. Topical hyaluronic acid in rhinitis medicamentosa: could our perspective be changed?
    Casale M, Vella P, Moffa A, Sabatino L, Rinaldi V, Grimaldi V, Salvinelli F.
    J Biol Regul Homeost Agents; 2017 Dec 27; 31(4 Suppl 2):55-62. PubMed ID: 29202563
    [Abstract] [Full Text] [Related]

  • 10. Rhinitis medicamentosa: the forgotten factor in nasal obstruction.
    Mabry RL.
    South Med J; 1982 Jul 27; 75(7):817-9. PubMed ID: 6178170
    [Abstract] [Full Text] [Related]

  • 11. [The rebound of nasal resistance after decongestant used in nose].
    Shen J, Huang X, Xiang J, Shu H.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec 27; 13(12):560-1. PubMed ID: 12541428
    [Abstract] [Full Text] [Related]

  • 12. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J.
    Eur Arch Otorhinolaryngol; 2009 May 27; 266(5):623-5. PubMed ID: 19096862
    [Abstract] [Full Text] [Related]

  • 13. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P, Hallén H.
    ORL J Otorhinolaryngol Relat Spec; 1997 May 27; 59(1):39-44. PubMed ID: 9104748
    [Abstract] [Full Text] [Related]

  • 14. Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse.
    Caffier PP, Frieler K, Scherer H, Sedlmaier B, Göktas O.
    Am J Rhinol; 2008 May 27; 22(4):433-9. PubMed ID: 18702912
    [Abstract] [Full Text] [Related]

  • 15. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
    Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE.
    B-ENT; 2009 May 27; 5(3):159-62. PubMed ID: 19902852
    [Abstract] [Full Text] [Related]

  • 16. Management of Rhinitis Medicamentosa: A Systematic Review.
    Zucker SM, Barton BM, McCoul ED.
    Otolaryngol Head Neck Surg; 2019 Mar 27; 160(3):429-438. PubMed ID: 30325708
    [Abstract] [Full Text] [Related]

  • 17. Rhinitis medicamentosa: a review of causes and treatment.
    Graf P.
    Treat Respir Med; 2005 Mar 27; 4(1):21-9. PubMed ID: 15725047
    [Abstract] [Full Text] [Related]

  • 18. Rhinitis medicamentosa. An experimental histopathological and histochemical study.
    Elwany SS, Stephanos WM.
    ORL J Otorhinolaryngol Relat Spec; 1983 Mar 27; 45(4):187-94. PubMed ID: 6192384
    [Abstract] [Full Text] [Related]

  • 19. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S, Holzhausen HJ, Riederer A, Bloching M.
    HNO; 2006 Oct 27; 54(10):742-8. PubMed ID: 16477462
    [Abstract] [Full Text] [Related]

  • 20. Extended use of topical nasal decongestants.
    Yoo JK, Seikaly H, Calhoun KH.
    Laryngoscope; 1997 Jan 27; 107(1):40-3. PubMed ID: 9001263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.